Discussing Genitourinary (GU) Cancers ASCO 2022
Practice changing studies with Dr. Shilpa Gupta, Director of Taussig Cancer Institute and Co-Leader GU Onc, Cleveland Clinic GU Malignancy.
Genitourinary (GU) ASCO 2022 Highlights with Dr. Shilpa Gupta
Share This: